by Andrea Mackie | Nov 7, 2023
Versiti, a national leader in blood health innovation, today announced the acquisition of Pearl Pathways, a recognized, trusted advisor and preferred partner for enabling innovative and expedited life science product development. Based in Indianapolis, Pearl Pathways...
by Andrea Mackie | Jul 26, 2023
Radiopharmaceuticals (RPs) are at the forefront of many diagnostic and therapeutic advancements, but the regulations surrounding their development and approval are extensive. Because RPs are appreciably different from standard pharmaceuticals, their regulatory process...
by Andrea Mackie | Jul 26, 2023
Traditionally used in diagnostics, innovative radiopharmaceutical (RP) technology is now increasingly used for therapeutic applications. RPs make for easier and more effective study of various body systems and organs—offering insight into conditions as well as...
